Literature DB >> 23709299

Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatment.

Ryan A Black1, Kimberlee J Trudeau, Theresa A Cassidy, Simon H Budman, Stephen F Butler.   

Abstract

OBJECTIVE: To determine what, if any, public health and societal impacts are associated specifically with injection of prescription opioids.
DESIGN: Cross-sectional observational study.
SETTING: Five hundred forty treatment facilities in 35 states across the United States performing Addiction Severity Index-Multimedia Version (ASI-MV) assessments. PARTICIPANTS: Adult patients (29,459) who reported past 30-day abuse of any prescription opioid on the ASI-MV assessment between January 2007 and January 2011. MAIN OUTCOME MEASURES: The public health indicators selected for this study were liver disease, HIV/AIDS status, recent visit to an emergency room, treatment for pain, treatment for overdosing, homelessness, residence with alcohol/substance abuser, and unemployment.
RESULTS: Prescription opioid injection was significantly associated with health problems, psychosocial problems, and utilization of medical services.
CONCLUSIONS: This study demonstrates an approach to measure the potential impact of injecting prescription opioids on public health indicators. Findings indicate a positive association between injection of prescription opioids and public health indicators suggesting a need for prescription opioid formulations that may inhibit injection of these medications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23709299     DOI: 10.5055/jom.2013.0142

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  9 in total

1.  Using medical examiner case narratives to improve opioid overdose surveillance.

Authors:  Emily Hurstak; Christopher Rowe; Caitlin Turner; Emily Behar; Rachel Cabugao; Nikolas P Lemos; Catherine Burke; Phillip Coffin
Journal:  Int J Drug Policy       Date:  2018-01-30

2.  Associations between prescription opioid injection and Hepatitis C virus among young injection drug users.

Authors:  Stephen E Lankenau; Aleksandar Kecojevic; Karol Silva
Journal:  Drugs (Abingdon Engl)       Date:  2015

Review 3.  The American Opioid Epidemic in Special Populations: Five Examples.

Authors:  Carlos Blanco; Mir M Ali; Aaron Beswick; Karen Drexler; Cheri Hoffman; Christopher M Jones; Tisha R A Wiley; Allan Coukell
Journal:  NAM Perspect       Date:  2020-10-26

Review 4.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

5.  Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004-2013.

Authors:  Christopher M Jones; Aleta Christensen; R Matthew Gladden
Journal:  Drug Alcohol Depend       Date:  2017-05-16       Impact factor: 4.852

6.  Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Nicholas Dinubile; John Giordano; Eric R Braverman; Courtney E Truesdell; Debmalya Barh; Rajendra Badgaiyan
Journal:  J Addict Res Ther       Date:  2013-10-31

7.  A Comparison of Substance Use Patterns Among Lifetime Heroin-Injecting Individuals By Racial Groups.

Authors:  Tabitha E H Moses; Jamey J Lister; Mark K Greenwald
Journal:  Addict Res Theory       Date:  2019-06-30

Review 8.  Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.

Authors:  Richard L Rauck
Journal:  Pain Pract       Date:  2019-02-28       Impact factor: 3.183

9.  High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.

Authors:  Mark Moran; Kenneth Blum; Jessica Valdez Ponce; Lisa Lott; Marjorie C Gondré-Lewis; Sampada Badgaiyan; Raymond Brewer; B William Downs; Philip Fynman; Alexander Weingarten; Jean Lud Cadet; David E Smith; David Baron; Panayotis K Thanos; Edward J Modestino; Rajendra D Badgaiyan; Igor Elman; Mark S Gold
Journal:  Mol Neurobiol       Date:  2021-03-08       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.